Human Glypican 5 quantitates human Glypican 5 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Glypican 5.
Human Glypican 5 quantitates human Glypican 5 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Glypican 5.
Human Glypican 5 quantitates human Glypican 5 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Glypican 5.
Cellular-surface d-heparane sulfate proteoglycans are composed of a protein nucleus associated with the membrane substituted for a variable number of d-heparane sulfate chains. Members of the family of integral membrane proteoglycans (GRIP) associated with glypican contain a nucleus protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol bond. These proteins can play a role in controlling cell division and growth regulation. [provided by RefSeq, July 2008].
Sensitivity
Sensitivity of the dosage: 1.3 ng/mL.
Measurement range
Dose range: 1.3 to 300 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Glypican 5.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).